98 related articles for article (PubMed ID: 8497616)
1. A new macromolecule as a contrast agent for MR angiography: preparation, properties, and animal studies.
Bogdanov AA; Weissleder R; Frank HW; Bogdanova AV; Nossif N; Schaffer BK; Tsai E; Papisov MI; Brady TJ
Radiology; 1993 Jun; 187(3):701-6. PubMed ID: 8497616
[TBL] [Abstract][Full Text] [Related]
2. Detection of pulmonary emboli by using MR angiography with MPEG-PL-GdDTPA: an experimental study in rabbits.
Frank H; Weissleder R; Bogdanov AA; Brady TJ
AJR Am J Roentgenol; 1994 May; 162(5):1041-6. PubMed ID: 8165978
[TBL] [Abstract][Full Text] [Related]
3. A macromolecular contrast agent for magnetic resonance imaging. Effect of molecular weight on blood pharmacokinetics and enhancement patterns for polylysine-gadopentetate dimeglumine.
Vexler VS; Clément O; Brasch RC
Invest Radiol; 1994 Jun; 29 Suppl 2():S62-4. PubMed ID: 7928273
[No Abstract] [Full Text] [Related]
4. Inflammation: imaging with methoxy poly(ethylene glycol)-poly-L-lysine-DTPA, a long-circulating graft copolymer.
Gupta H; Wilkinson RA; Bogdanov AA; Callahan RJ; Weissleder R
Radiology; 1995 Dec; 197(3):665-9. PubMed ID: 7480736
[TBL] [Abstract][Full Text] [Related]
5. Macromolecular intravenous contrast agent for MR lymphography: characterization and efficacy studies.
Harika L; Weissleder R; Poss K; Papisov MI
Radiology; 1996 Feb; 198(2):365-70. PubMed ID: 8596833
[TBL] [Abstract][Full Text] [Related]
6. Effect of varying the molecular weight of the MR contrast agent Gd-DTPA-polylysine on blood pharmacokinetics and enhancement patterns.
Vexler VS; Clément O; Schmitt-Willich H; Brasch RC
J Magn Reson Imaging; 1994; 4(3):381-8. PubMed ID: 8061437
[TBL] [Abstract][Full Text] [Related]
7. Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system.
Schuhmann-Giampieri G; Schmitt-Willich H; Press WR; Negishi C; Weinmann HJ; Speck U
Radiology; 1992 Apr; 183(1):59-64. PubMed ID: 1549695
[TBL] [Abstract][Full Text] [Related]
8. [A comparative study between Gd-BOPTA, a biliary excretion contrast medium, and Gd-DTPA in the magnetic resonance imaging of the rat liver].
Patrizio G; Pavone P; Cardone G; Pietroletti R; Passariello R; Tettamanti E; Musu C; Felder E
Radiol Med; 1990 May; 79(5):458-62. PubMed ID: 2359853
[TBL] [Abstract][Full Text] [Related]
9. Gadolinium-ethoxybenzyl-DTPA, a new liver-specific magnetic resonance contrast agent. Kinetic and enhancement patterns in normal and cholestatic rats.
Clément O; Mühler A; Vexler V; Berthezène Y; Brasch RC
Invest Radiol; 1992 Aug; 27(8):612-9. PubMed ID: 1428739
[TBL] [Abstract][Full Text] [Related]
10. Myocardial infarction: assessment with an intravascular MR contrast medium. Work in progress.
Saeed M; Wendland MF; Masui T; Connolly AJ; Derugin N; Brasch RC; Higgins CB
Radiology; 1991 Jul; 180(1):153-60. PubMed ID: 2052685
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Gd-BOPTA with Gd-DTPA in MR imaging of rat liver.
Pavone P; Patrizio G; Buoni C; Tettamanti E; Passariello R; Musu C; Tirone P; Felder E
Radiology; 1990 Jul; 176(1):61-4. PubMed ID: 2353112
[TBL] [Abstract][Full Text] [Related]
12. Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA.
Vogl TJ; Kümmel S; Hammerstingl R; Schellenbeck M; Schumacher G; Balzer T; Schwarz W; Müller PK; Bechstein WO; Mack MG; Söllner O; Felix R
Radiology; 1996 Jul; 200(1):59-67. PubMed ID: 8657946
[TBL] [Abstract][Full Text] [Related]
13. Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging.
Hamm B; Staks T; Mühler A; Bollow M; Taupitz M; Frenzel T; Wolf KJ; Weinmann HJ; Lange L
Radiology; 1995 Jun; 195(3):785-92. PubMed ID: 7754011
[TBL] [Abstract][Full Text] [Related]
14. Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence.
Reimer P; Rummeny EJ; Shamsi K; Balzer T; Daldrup HE; Tombach B; Hesse T; Berns T; Peters PE
Radiology; 1996 Apr; 199(1):177-83. PubMed ID: 8633143
[TBL] [Abstract][Full Text] [Related]
15. Experimental gastrointestinal hemorrhage: detection with contrast-enhanced MR imaging and scintigraphy.
Gupta H; Weissleder R; Bogdanov AA; Brady TJ
Radiology; 1995 Jul; 196(1):239-44. PubMed ID: 7784574
[TBL] [Abstract][Full Text] [Related]
16. Comparison of gadolinium-DTPA and polylysine-gadolinium-DTPA--enhanced magnetic resonance imaging of hepatocarcinoma in the rat.
Grandin C; Van Beers BE; Demeure R; Goudemant JF; Mottet I; Pringot J
Invest Radiol; 1995 Oct; 30(10):572-81. PubMed ID: 8557496
[TBL] [Abstract][Full Text] [Related]
17. [3D-MR-angiography using Gd-DTPA].
Seiderer M; Bauer WM; Villringer A; Einhäupl K
Rofo; 1990 Mar; 152(3):327-32. PubMed ID: 2157258
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Gd [DTPA-bis (2-aminoethoxy) ethane] polymeric contrast agent with gadodiamide injection for interstitial MR lymphography: experimental study with rabbits.
Zhou Z; Guo J; Yu H; Zhu B; Liu C; Jiang X; Zhang M; Chen J
J Magn Reson Imaging; 2005 Sep; 22(3):361-7. PubMed ID: 16106365
[TBL] [Abstract][Full Text] [Related]
19. Comparison of gadolinium-DTPA and macromolecular gadolinium-DTPA-polylysine for contrast-enhanced pulmonary time-of-flight magnetic resonance angiography.
Böck JC; Kaufmann F; Felix R
Invest Radiol; 1996 Oct; 31(10):652-7. PubMed ID: 8889654
[TBL] [Abstract][Full Text] [Related]
20. Cascade polymeric MRI contrast media derived from poly(ethylene glycol) cores: initial syntheses and characterizations.
Fu Y; Raatschen HJ; Nitecki DE; Wendland MF; Novikov V; Fournier LS; Cyran C; Rogut V; Shames DM; Brasch RC
Biomacromolecules; 2007 May; 8(5):1519-29. PubMed ID: 17402781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
